Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients
Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients
Early diagnosis and appropriate treatment for COPD subjects are both critical to minimize the
 progression of COPD and improve outcomes. Also, evidence suggests that high eosinophil
 (specific type of white blood cell that protects body against certain kinds of germs) level
 is associated with increased risk of both moderate and severe exacerbations in COPD subjects.
 To date, there is insufficient amount of data that describes the prevalence of COPD in
 Brazilian primary care units. Thus, this multicenter, cross-sectional study conducted in five
 centers located in five different Brazilian cities will provide estimation about the
 prevalence of COPD in primary care and will also determine the levels of eosinophils in
 subjects with confirmed COPD diagnosis. Approximately 2,500 eligible subjects are expected to
 be enrolled in the study.
The study is a cross sectional (prevalence study).
Inclusion Criteria:

 -  Adult >= 35 years old

 -  At least one of the following risk factors for COPD:

 • being a current smoker (who has smoked 100 cigarettes in his or her lifetime and who
 currently smokes cigarettes) or past smoker (who has smoked at least 100 cigarettes in
 his or her lifetime but who had quit smoking at the time of interview); Current or
 past exposure to biomass smoke, such as wood or coal, for cooking or heating (exposure
 >=100 hours/year

 -  Capable of giving signed informed consent

 Exclusion Criteria:

 -  Physical or mental disability to complete the study procedures

 -  Heart above 120 beats per minute

 -  Participants under treatment for tuberculosis

 -  Participant in current clinical trial

 -  Pregnancy

 -  Patients with one of the following contraindications to spirometry: chest surgery in
 the last month; abdominal surgery within the past three months; neuromuscular disease,
 acute coronary syndrome; retinal detachment; hospitalization for any cardiac problem
 in the prior 3 months.